Feng Jin

9.5k total citations
77 papers, 673 citations indexed

About

Feng Jin is a scholar working on Oncology, Molecular Biology and Otorhinolaryngology. According to data from OpenAlex, Feng Jin has authored 77 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 25 papers in Molecular Biology and 24 papers in Otorhinolaryngology. Recurrent topics in Feng Jin's work include Head and Neck Cancer Studies (24 papers), Lung Cancer Research Studies (17 papers) and Lung Cancer Treatments and Mutations (11 papers). Feng Jin is often cited by papers focused on Head and Neck Cancer Studies (24 papers), Lung Cancer Research Studies (17 papers) and Lung Cancer Treatments and Mutations (11 papers). Feng Jin collaborates with scholars based in China, United States and South Korea. Feng Jin's co-authors include Jinhua Long, Wei-Li Wu, Srini Ramanathan, Sophia Randolph, Jaume Pons, Huafeng Zhou, Nehal J. Lakhani, Justin F. Gainor, Hong Wan and Pierre Squifflet and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Feng Jin

73 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Feng Jin China	15	272	158	149	123	114	77	673
Antônio Hugo José Fróes Marques Campos Brazil	16	175 0.6×	269 1.7×	79 0.5×	56 0.5×	22 0.2×	40	599
Pekka Mali Finland	12	202 0.7×	288 1.8×	66 0.4×	152 1.2×	35 0.3×	15	699
Sugandha Saxena United States	14	438 1.6×	228 1.4×	407 2.7×	92 0.7×	8 0.1×	28	832
Shane Foo United Kingdom	7	195 0.7×	228 1.4×	241 1.6×	49 0.4×	3 0.0×	12	508
Ming Cao United States	12	131 0.5×	175 1.1×	186 1.2×	26 0.2×	32 0.3×	21	553
Bert Bier Germany	11	232 0.9×	302 1.9×	24 0.2×	68 0.6×	6 0.1×	21	690
Jennifer Leary Australia	16	223 0.8×	263 1.7×	40 0.3×	40 0.3×	13 0.1×	18	629
Itaru Sonoda Japan	9	153 0.6×	321 2.0×	29 0.2×	83 0.7×	93 0.8×	20	528
Jean‐François Laes Belgium	12	146 0.5×	317 2.0×	119 0.8×	114 0.9×	3 0.0×	26	692

Countries citing papers authored by Feng Jin

Since Specialization

Citations

This map shows the geographic impact of Feng Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Jin more than expected).

Fields of papers citing papers by Feng Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Jin. The network helps show where Feng Jin may publish in the future.

Co-authorship network of co-authors of Feng Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Jin. A scholar is included among the top collaborators of Feng Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Jin. Feng Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Taotao, Yue Chen, Yu Zhou, et al.. (2024). Gemcitabine plus cisplatin versus docetaxel plus cisplatin and fluorouracil induction chemotherapy combined with locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A single center prospective phase II clinical trial. Oral Oncology. 159. 107087–107087.

Chen, Qiuyan, Hai‐Qiang Mai, Dongping Chen, et al.. (2024). Four-year overall survival follow-up and dynamic EBV titer analysis of toripalimab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (r/m NPC).. Journal of Clinical Oncology. 42(16_suppl). 6039–6039. 2 indexed citations

Yang, Xueyan, Yu‐Xin Tian, Feng Jin, et al.. (2024). Dose-dependent Relationship between Alcohol Consumption and the Risks of Hepatitis B Virus-associated Cirrhosis and Hepatocellular Carcinoma: A Meta-analysis and Systematic Review. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 2 indexed citations

Chen, Qiuyan, Shanshan Guo, Ying Luo, et al.. (2024). Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study. Oral Oncology. 151. 106723–106723. 11 indexed citations

Jin, Feng, et al.. (2024). Expression profile of circular RNAs in blood samples of Northern Chinese males with intracerebral hemorrhage shows downregulation of hsa-circ-0090829. Heliyon. 10(16). e35864–e35864. 2 indexed citations

Li, Yuanyuan, Yue Chen, Yuxin Li, et al.. (2024). Dickkopf-1 is an immune infiltration-related prognostic biomarker of head and neck squamous cell carcinoma. Aging. 16(4). 3837–3855. 1 indexed citations

Sun, Ying, Ye‐Lin Liang, Liangfang Shen, et al.. (2024). PD-1 blockade with camrelizumab after chemoradiotherapy in nasopharyngeal carcinoma.. Journal of Clinical Oncology. 42(23_suppl). 129–129. 1 indexed citations

Liu, Jilan, et al.. (2023). Function of Long Noncoding RNAs in Glioma Progression and Treatment Based on the Wnt/β-Catenin and PI3K/AKT Signaling Pathways. Cellular and Molecular Neurobiology. 43(8). 3929–3942. 5 indexed citations

Li, Yuanyuan, Lina Liu, Jieqing Jiang, et al.. (2022). Circadian clock gene BMAL1 inhibits the proliferation and tumor-formation ability of nasopharyngeal carcinoma cells and increases the sensitivity of radiotherapy. Chronobiology International. 39(10). 1340–1351. 11 indexed citations

10.

Wang, Fen, Feng Jin, Boran Cheng, et al.. (2021). The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 148(7). 1721–1735. 8 indexed citations

11.

Mai, Hai‐Qiang, Shaojun Lin, Dongping Chen, et al.. (2021). 436 A phase II study of AK104, a bispecific antibody targeting PD-1 and CTLA-4, in patients with metastatic nasopharyngeal carcinoma (NPC) who had progressed after two or more lines of chemotherapy. Regular and Young Investigator Award Abstracts. A466–A466. 14 indexed citations

12.

Chung, Hyun Cheol, Kyungwon Lee, Justin F. Gainor, et al.. (2021). SO-31 ASPEN-01: A phase 1 study of ALX148, a CD47 blocker, in combination with trastuzumab, ramucirumab and paclitaxel in patients with second-line HER2-positive advanced gastric or gastroesophageal junction cancer. Annals of Oncology. 32. S215–S216. 10 indexed citations

13.

Zhang, Xiaowei, Feng Jin, Shiyu Jiang, et al.. (2021). Rh-endostatin combined with chemotherapy in patients with advanced or recurrent mucosal melanoma: retrospective analysis of real-world data. Investigational New Drugs. 40(2). 453–460. 7 indexed citations

14.

Long, Jinhua, Shichao Zhang, Yan Ouyang, et al.. (2020). Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma. Frontiers in Molecular Biosciences. 7. 586344–586344. 6 indexed citations

15.

Li, Yuanyuan, Feng Jin, Fang Yu, et al.. (2019). Downregulation of the circadian Period family genes is positively correlated with poor head and neck squamous cell carcinoma prognosis. Chronobiology International. 36(12). 1723–1732. 10 indexed citations

16.

Li, Yuanyuan, et al.. (2019). A phase II multicenter randomized controlled trial to compare standard chemoradiation with or without recombinant human endostatin injection (Endostar) therapy for the treatment of locally advanced nasopharyngeal carcinoma: Long-term outcomes update. Current Problems in Cancer. 44(1). 100492–100492. 14 indexed citations

17.

Jin, Feng, Wei-Li Wu, Yuanyuan Li, et al.. (2018). An analysis on the combination of chrono-chemotherapy with different speed rate and concomitant intensity-modulated radiotherapy in the treatment of locally advanced nasopharyngeal carcinoma. Zhonghua fangshe yixue yu fanghu zazhi. 38(4). 278–284. 1 indexed citations

18.

Jin, Feng, Xiaoxia Gou, Wei-Li Wu, et al.. (2018). Induction chronomodulated chemotherapy plus radiotherapy for nasopharyngeal carcinoma: A Phase II prospective randomized study. Journal of Cancer Research and Therapeutics. 14(7). 1613–1613. 14 indexed citations

19.

Li, Yuanyuan, et al.. (2017). A clinical study of perfusion weighted magnetic resonance imaging in recombinant human endostatin combined with chemotherapy and radiotherapy for locally advanced nasopharyngeal carcinoma. Zhonghua fangshe yixue yu fanghu zazhi. 37(4). 264–268.

20.

Tian, Ling, et al.. (2010). Juvenile hormone III produced in male accessory glands of the longhorned beetle, Apriona germari, is transferred to female ovaries during copulation. Archives of Insect Biochemistry and Physiology. 75(1). 57–67. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact